🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2846975 63 F TX 06/23/2025 CHIK
 BAVARIAN NORDIC
 LN4929
Erythema, Skin warm Erythema, Skin warm
Left shoulder with erythema and warmth. MD prescribed cephalexin (10 day course) and cetirizine. Left shoulder with erythema and warmth. MD prescribed cephalexin (10 day course) and cetirizine.
2846976 8 M VA 06/23/2025 MNQ
RAB
 SANOFI PASTEUR
NOVARTIS VACCINES AND DIAGNOSTICS
 U83698A
FDP00683
Injection site pruritus, Injection site urticaria; Injection site pruritus, Inje... Injection site pruritus, Injection site urticaria; Injection site pruritus, Injection site urticaria More
First simultaneous itching at both vaccine injection sites then Hives at both upper arm injection si... First simultaneous itching at both vaccine injection sites then Hives at both upper arm injection sites that included the back shoulders; immediately gave 5ml of children's Benadryl repeated in 5 minutes with a second dose of 5 ml per child's weight of 59 #. No respiratory involvement. EMS called and assessed Pt. Normal Vital signs. SpO2 94%. No progression of hives. Itching resolved. EMS agreed with treatment plan and discharged Pt. to mother's choice to see PMD. Continued to observe Pt. an hour before discharge to PMD. More
2846977 1.67 CA 06/23/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 Y49BZ
Product administered to patient of inappropriate age, Wrong product administered Product administered to patient of inappropriate age, Wrong product administered
20 month old that received Kinrix; Incorrect vaccine/the patient needed the Dtap/IPV immunization; T... 20 month old that received Kinrix; Incorrect vaccine/the patient needed the Dtap/IPV immunization; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 20-month-old patient who received DTPa-IPV (Kinrix) (batch number Y49BZ, expiry date 17-MAY-2026) for prophylaxis. Co-suspect products included DTPa-IPV (DTPa-IPV) for prophylaxis. On an unknown date, the patient received Kinrix and DTPa-IPV. On an unknown date, an unknown time after receiving Kinrix and not applicable after receiving DTPa-IPV, the patient experienced inappropriate age at vaccine administration (Verbatim: 20 month old that received Kinrix) and wrong vaccine administered (Verbatim: Incorrect vaccine/the patient needed the Dtap/IPV immunization). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUN-2025 The nurse reported that they had a 20-month-old patient that received Kinrix which led to inappropriate age at vaccine administration, and he/she was asked to follow-up if there is any concern or anything that need to be done. When asked what vaccine was supposed to receive, the nurse answered that the patient needed the Dtap/IPV immunization for the patient's age which led to wrong vaccine administered. More
2846978 67 F AL 06/23/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 7MN4C
Chills, Tremor Chills, Tremor
Per RN, pt had Bexsero 3rd dose, left office, returned and about 3 hrs later to ambulatory suite an... Per RN, pt had Bexsero 3rd dose, left office, returned and about 3 hrs later to ambulatory suite and had severe shills and shaking for approximately 45 mins. More
2846979 M IN 06/23/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 9L944
Product preparation error Product preparation error
Shingrix possible powder administration with another diluent than the one provided; Shingrix possibl... Shingrix possible powder administration with another diluent than the one provided; Shingrix possible powder administration with another diluent than the one provided; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a elderly male patient who received Herpes zoster (Shingrix) (batch number 9L944, expiry date 30-MAR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Shingrix possible powder administration with another diluent than the one provided) and inappropriate preparation of medication (Verbatim: Shingrix possible powder administration with another diluent than the one provided). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 13-JUN-2025 and 14-JUN-2025 Practice manager wanted to know how to proceed after finding a Shingrix box 2 with an odd number of vials only including the diluent, so she was supposing that the powder was administered to a patient using another diluent (saline water) than the one provided which led to Inappropriate dose of vaccine administered and Inappropriate preparation of medication. Also, mentioned that she still needed to find out who was the patient that received it. Recommendation was given about contacting the medical information team again if she finds out the patient involved and date of administration. More
2846980 1 M MD 06/23/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 BR2GD
Expired product administered Expired product administered
Expired dose given; This non-serious case was reported by a other health professional via call cente... Expired dose given; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 14-month-old male patient who received HAV (Havrix) (batch number BR2GD, expiry date 16-MAY-2025) for prophylaxis. On 13-JUN-2025, the patient received the 1st dose of Havrix. On 13-JUN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-JUN-2025 The healthcare professional called in to report that they accidentally administered two doses of expired Havrix to two patients which led to, expired vaccine used. The Vaccine Administration Facility was the same as Primary Reporter. More
2846981 1 M MD 06/23/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 BR2GD
Expired product administered Expired product administered
Expired dose given; This non-serious case was reported by a other health professional via call cente... Expired dose given; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-month-old male patient who received HAV (Havrix) (batch number BR2GD, expiry date 16-MAY-2025) for prophylaxis. On 13-JUN-2025, the patient received Havrix. On 13-JUN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-JUN-2025 A healthcare professional called in to report that they accidentally administered 2 doses of expired Havrix to 2 patients, which led to expired vaccine used. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. The case had been linked to US2025074252, reported by the same reporter for a different patient.; Sender's Comments: US-GSK-US2025074252:same reporter /different patient More
2846982 KY 06/23/2025 HIBV
 GLAXOSMITHKLINE BIOLOGICALS
Intercepted product preparation error, Product preparation error Intercepted product preparation error, Product preparation error
Hiberix - Incorrect vaccine preparation/used the diluent of Priorix for the Hiberix vaccine; This no... Hiberix - Incorrect vaccine preparation/used the diluent of Priorix for the Hiberix vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of intercepted product preparation error in a patient who received Hib (Hiberix) for prophylaxis. On an unknown date, the patient did not receive Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced intercepted product preparation error (Verbatim: Hiberix - Incorrect vaccine preparation/used the diluent of Priorix for the Hiberix vaccine). The outcome of the intercepted product preparation error was not applicable. Additional Information: GSK receipt date: 13-JUN-2025 A nurse mentioned they used the diluent of Priorix for the Hiberix vaccine, and the reporter confirmed that the dose was not administered, which led to intercepted product preparation error. The reporter asked if the diluents were the same or if they were different. No further details were provided by the reporter. More
2846983 68 F 06/23/2025 RSV
 MODERNA
 3041772
Device issue, No adverse event Device issue, No adverse event
removing the cap (where the needle is located) was also hard to remove; the vaccine's plunger w... removing the cap (where the needle is located) was also hard to remove; the vaccine's plunger was "very hard" to push when the HCP administered the vaccine/ the plunger was extremely heavy and was hard to push/issue with the plunger being extremely heavy; No adverse effect; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE DIFFICULT TO USE (removing the cap (where the needle is located) was also hard to remove), DEVICE ISSUE (the vaccine's plunger was "very hard" to push when the HCP administered the vaccine/ the plunger was extremely heavy and was hard to push/issue with the plunger being extremely heavy) and NO ADVERSE EVENT (No adverse effect) in a 68-year-old female patient who received mRNA-1345 (mRESVIA) (batch no. 3041772) for Respiratory syncytial virus infection prophylaxis. Co-suspect product included Pre-filled Syringe injection (batch no. 3041772) for Respiratory syncytial virus infection prophylaxis. No Medical History information was reported. On 17-Jun-2025, the patient received dose of mRNA-1345 (mRESVIA) (Intramuscular use) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On an unknown date, the patient experienced DEVICE DIFFICULT TO USE (removing the cap (where the needle is located) was also hard to remove), DEVICE ISSUE (the vaccine's plunger was "very hard" to push when the HCP administered the vaccine/ the plunger was extremely heavy and was hard to push/issue with the plunger being extremely heavy) and NO ADVERSE EVENT (No adverse effect). At the time of the report, DEVICE DIFFICULT TO USE (removing the cap (where the needle is located) was also hard to remove), DEVICE ISSUE (the vaccine's plunger was "very hard" to push when the HCP administered the vaccine/ the plunger was extremely heavy and was hard to push/issue with the plunger being extremely heavy) and NO ADVERSE EVENT (No adverse effect) outcome was unknown. For mRNA-1345 (mRESVIA) (Intramuscular use), the reporter did not provide any causality assessments. For Pre-filled Syringe, the reporter did not provide any causality assessments. No concomitant medications were reported. HCP mentioned that they encountered a plunger error on a syringe that was administered to a patient. HCP reported that the vaccine's plunger was heavy and was very hard to push and removing the cap, where the needle was located was also hard to remove. HCP wanted a product replacement on a syringe they used to administer to a patient. HCP reported that was successfully administered to a patient. It was reported that only one syringe was used and only one patient received the vaccine. A possible occupational exposure of vaccine during administration due to plunger problem was considered. No adverse events were reported after the vaccination. No treatment medications were reported. The Device Problem Information include FDA code: 1670, IMDRF Code: A23, Device problem: Use of Device Problem. Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2025: Live Follow up received that contains non-significant information and reference ID added. On 17-Jun-2025: Live Follow up received contains non-significant information and reference ID added. On 17-Jun-2025: Live Follow up received contains non-significant information and reference ID added. On 17-Jun-2025: Live follow-up received contains significant information and reporter details updated, patient details updated, new event added, narrative updated, reference ID added On 18-Jun-2025: Live Follow up received that contains non-significant information and reference ID added. On 18-Jun-2025: Live Follow-up received contains significant information and event LLT updated, Reference ID added. More
2846985 F 06/23/2025 PNC20
 PFIZER\WYETH
 LP4947
Injection site cellulitis, Injection site reaction, Rash erythematous Injection site cellulitis, Injection site reaction, Rash erythematous
red rash at site of injection/likely celulitis; red rash at site of injection/likely celulitis; This... red rash at site of injection/likely celulitis; red rash at site of injection/likely celulitis; This is a spontaneous report received from a Physician. A 67-year-old female patient (not pregnant) received pneumococcal 20-valent conjugated vaccine (diphtheria CRM197 protein) (PREVNAR 20), on 12Jun2025 as dose number unknown, single (Lot number: LP4947) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Penicillin, reaction(s): "Hypersensitivity"; Bactrim, reaction(s): "Hypersensitivity"; Tetracycline, reaction(s): "Hypersensitivity". The following information was reported: VACCINATION SITE CELLULITIS (non-serious), VACCINATION SITE RASH (non-serious) all with onset 13Jun2025, outcome "unknown" and all described as "red rash at site of injection/likely celulitis". Therapeutic measures were taken as a result of vaccination site cellulitis, vaccination site rash. Additional information: The patient did not receive any other vaccines on the same date as the vaccine(s) for which you are reporting. The patient did not receive any other vaccines within 4 weeks prior to the vaccine(s) for which you are reporting. The patient taking any other medications within 2 weeks of the event starting. Treatment received for the adverse event included antibiotic. Causality for "red rash at site of injection/likely celulitis" was determined associated to device constituent of pneumococcal 20-val conj vac (dipht CRM197 protein) (malfunction). More
2846986 30 F FL 06/23/2025 RSV
 PFIZER\WYETH
Chills, Diarrhoea, Nausea, Pain, Vomiting Chills, Diarrhoea, Nausea, Pain, Vomiting
Severe vomiting; diarrhoea; Nausea; Chills; Body ache; This is a spontaneous report received from a ... Severe vomiting; diarrhoea; Nausea; Chills; Body ache; This is a spontaneous report received from a Consumer or other non HCP. A 30-year-old female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 05Jun2025 at 15:00 as dose 1, single (Batch/Lot number: unknown) at the age of 30 years, in left arm for immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAIN (hospitalization) with onset 06Jun2025 at 10:00, outcome "recovered" (10Jun2025), described as "Body ache"; CHILLS (hospitalization) with onset 06Jun2025 at 10:00, outcome "recovered" (10Jun2025); NAUSEA (hospitalization) with onset 06Jun2025 at 10:00, outcome "recovered" (10Jun2025); VOMITING (hospitalization) with onset 06Jun2025 at 10:00, outcome "recovered" (10Jun2025), described as "Severe vomiting"; DIARRHOEA (hospitalization) with onset 06Jun2025 at 10:00, outcome "recovered" (10Jun2025). The patient was hospitalized for vomiting, diarrhoea, nausea, chills, pain (hospitalization duration: 1 day(s)). Therapeutic measures were taken as a result of vomiting, diarrhoea, nausea, chills, pain. The information on the batch/lot number for rsv vaccine prot.subunit pref 2v will be requested and submitted if and when received. More
✓
2846987 06/23/2025 PNC20
 PFIZER\WYETH
Parotitis Parotitis
parotitis/My parotid gland on the left-hand side is swollen; This is a spontaneous report received f... parotitis/My parotid gland on the left-hand side is swollen; This is a spontaneous report received from a Pharmacist. A patient (age and gender not provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 19Jun2025 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAROTITIS (non-serious) with onset 20Jun2025, outcome "unknown", described as "parotitis/My parotid gland on the left-hand side is swollen". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2846988 F 06/23/2025 COVID19
 PFIZER\BIONTECH
Neurodermatitis Neurodermatitis
prurigo nodularis developed after the covid vaccine; This is a spontaneous report received from a Co... prurigo nodularis developed after the covid vaccine; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): 2025SA153013 (Sanofi). A 62-year-old female patient (unknown if pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; dupilumab (DUPIXENT), since 12Dec2022 (Lot number: 4F595A, Expiration Date: 30Nov2026) at 300 mg (300 mg qow), subcutaneous for dermatitis atopic. The patient's relevant medical history included: "atopic dermatitis" (ongoing). Concomitant medication(s) included: CALCIPOTRIENE; SULFACETAMIDE SODIUM AND SULFUR [SULFACETAMIDE SODIUM;SULFUR]; NALTREXONE HCL. The following information was reported: NEURODERMATITIS (non-serious), outcome "unknown", described as "prurigo nodularis developed after the covid vaccine". The action taken for dupilumab was unknown. Additional information: It was reported patient said that when she was taking dupixent she formed abscesses more than once and the medication was not working. Patient had been started on nemluvio therapy. patient stated prurigo nodularis developed after the covid vaccine. no other details were provided'. An unknown (nemluvio therapy) corrective treatment was received for abscess and not reported for neurodermatitis." Batch/lot number is not provided, and it cannot be obtained. BNT162B2 OMICRON (KP.2) is under agreement with BIONTECH SE. More
2846989 0.33 M FL 06/23/2025 DTAPIPVHIB
 SANOFI PASTEUR
 K1098A
No adverse event, Product preparation issue No adverse event, Product preparation issue
PENTACEL was administered without the ActHib portion with no reported adverse event; Initial informa... PENTACEL was administered without the ActHib portion with no reported adverse event; Initial information received on 20-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 months old male patient who received diphtheria/tetanus/5 hybrid AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] without the ACT-HIB portion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20); and Rotavirus vaccine live oral 1v (Rotarix) as both for Immunisation. On 16-Jun-2025, the patient received 0.5 ml of diphtheria/tetanus/5 hybrid AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) vaccine Powder and suspension for suspension for injection with strength- standard (expiry date- 30-SEP-2025 and lot K1098A) once via unknown route in unknown administration site for Immunization, without the ACT-HIB portion with no reported adverse event (single component of a two-component product administered) (latency- same day). Reportedly, Caller inquiring if the DTaP-IPV portion would be valid and then if the Act-Hib portion could be administered separately. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2846990 12 M NV 06/23/2025 DTAP
 SANOFI PASTEUR
 3CA55C1
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
medical assistants accidentally administered daptacel to a 12-year-old patient with no reported adve... medical assistants accidentally administered daptacel to a 12-year-old patient with no reported adverse event; Initial information received on 20-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 years old male patient who was accidentally administered with Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel] by medical assistant to a 12-year-old patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine and Meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) both for Immunisation. On 20-Jun-2025, the patient received 0.5mL of suspect Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine, Suspension for injection (lot 3CA55C1, expiry date 31-Aug-2026, strength standard and frequency once) via intramuscular route in the left deltoid for Immunisation and was accidentally administered to a 12-year-old patient with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Reportedly, they wanted to know if they need to revaccinate and what they should look out for. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2846991 33 M MI 06/23/2025 TD
TDAP
 SANOFI PASTEUR
SANOFI PASTEUR
 U7927AA
No adverse event, Wrong product administered; No adverse event, Wrong product ad... No adverse event, Wrong product administered; No adverse event, Wrong product administered More
patient was supposed to receive adacel, but they received tenivac with no reported adverse event; In... patient was supposed to receive adacel, but they received tenivac with no reported adverse event; Initial information received on 20-Jun-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 33 years old male who was supposed to receive diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel], but they received diphtheria-2/tetanus-5 adsorbed toxoids NO preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On 20-JUN-2025 the patient was supposed to receive diphtheria-2/tetanus/5 AC pertussis vaccine, but they received 0.5 of suspect diphtheria-2/tetanus-5 adsorbed toxoids NO preservative adult Suspension for injection of standard strength, frequency once with lot U7927AA and expiry date 13-Oct-2025 via intramuscular route in the left deltoid for Immunization with no reported adverse event (wrong product administered) (latency same day). Reportedly, The pharmacist explains that the patient's wife is giving birth soon, which is why he needs pertussis coverage. When he was vaccinated, he was expecting pertussis coverage. However, he was erroneously given tenivac; he did not receive adacel. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2846992 55 F MO 06/23/2025 PNC21
 MERCK & CO. INC.
 Y019157
Erythema, Skin warm, Swelling Erythema, Skin warm, Swelling
Redness and swelling that has progressively gotten worse since the 21st of June...area is warm, red ... Redness and swelling that has progressively gotten worse since the 21st of June...area is warm, red and swollen at an area of 3.5 " x 2.75" More
2846993 66 F MI 06/23/2025 TDAP
 SANOFI PASTEUR
Muscle spasms Muscle spasms
Lower leg cramping for 2 days. Lower leg cramping for 2 days.
2847001 25 F CA 06/23/2025 COVID19
HPV9
 PFIZER\BIONTECH
MERCK & CO. INC.
 me6072
z005469
Fall, Hypoacusis, Peripheral coldness, Thirst, Tunnel vision; Fall, Hypoacusis, ... Fall, Hypoacusis, Peripheral coldness, Thirst, Tunnel vision; Fall, Hypoacusis, Peripheral coldness, Thirst, Tunnel vision More
After giving pt the 2 vaccines, we asked the pt to stay for 15 minutes for observations. A few minut... After giving pt the 2 vaccines, we asked the pt to stay for 15 minutes for observations. A few minutes later, heard mom calling out pt's name. Stepped out to see pt (sitting on chair) slowly falling to her left side. Mom was able to catch pt before she hit her head on the floor. So pt never hit her head. Pt was pale, and her hands were cold to the touch. Pt did not have any breathing issues, or anything other extreme symptoms. We asked pt and mom if they needed us to call 911, but they said not needed. Per mom, while talking to pt, pt asked for water, and then her eyes become unfocused and she started to fall sideway, while sitting. Per pt, she said she was feeling anxious/emotional prior to getting vaccines, as she always feel anxious prior to getting any vaccines. Pt stated that she felt thirsty, had tunnel vision, and muffled hearing. Upon being pulled up from the floor, pt said she felt like she was asleep, and that she was waking from her sleep. She knew she was at the pharmacy, and felt embarrassed for what had happened. She kept saying sorry. Upon feeling more alert after a couple of minutes, pt asked for water, and we went and got pt a bottle of cold water. Again, pt refused 911 call. We asked pt and mom to remain in pharmacy area for at least 30 minutes to make sure everything is ok. we checked on pt multiple time and pt was feeling much better, more alert, and had colors back, and hands not as clammy. After 30 minutes, pt and mom left the pharmacy on their own, since pt said she felt better. More
2847002 77 F CA 06/23/2025 COVID19
 MODERNA
 3046734
Eye movement disorder, Mental status changes Eye movement disorder, Mental status changes
Change in condition related to altered mental status and abnormal vital signs. On 6/22/2025 @ 1749, ... Change in condition related to altered mental status and abnormal vital signs. On 6/22/2025 @ 1749, resident noted with BP 136/86, Pulse 102, Temperature 98.6, Oxygen saturation 73% on Room Air, BS 124 mg/dl. Resident noted to have eyes rolling to back of head, unable to hold arms up during assessment, only responded to pain stimulation (Sternal rub), Resident transferred to Hospital for further evaluation. More
2847003 68 F FL 06/23/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 p2443
Pruritus, Urticaria Pruritus, Urticaria
Patient got severe hives and itching Patient got severe hives and itching
2847004 70 F GA 06/23/2025 PNC20
 PFIZER\WYETH
 LJ5283
Extra dose administered Extra dose administered
Patient received a 2nd dose of Prevnar 20 on accident. First dose was 4/24/2024 in a different state... Patient received a 2nd dose of Prevnar 20 on accident. First dose was 4/24/2024 in a different state. More
2847005 0.17 F MI 06/23/2025 DTPPVHBHPB
 MSP VACCINE COMPANY
 V7788AA
Vomiting projectile Vomiting projectile
Projectile vomited for the first time in her life about 5-6 hours after vaccine Projectile vomited for the first time in her life about 5-6 hours after vaccine
2847006 4 F NE 06/23/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 7745R
Y013576
Injection site urticaria; Injection site urticaria Injection site urticaria; Injection site urticaria
Hives around the vaccine site. Hives around the vaccine site.
2847007 74 F CO 06/23/2025 COVID19
 MODERNA
 3046714
Pruritus, Rash, Swelling Pruritus, Rash, Swelling
patient presented to the pharmacy 6/18/2025 at 4PM with large raised bump, raised and hot to touch, ... patient presented to the pharmacy 6/18/2025 at 4PM with large raised bump, raised and hot to touch, approximately softball size. reported it at coming on next day after vaccination 6/17/2025 and itchy. Reported taking benadryl and applying ice. More
2847008 52 F MT 06/23/2025 PNC21
PNC21
PNC21
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 Y011819
Y011819
Y011819
Asthenia, Chills, Fatigue, Injection site pain, Myalgia; Nausea, Oedema peripher... Asthenia, Chills, Fatigue, Injection site pain, Myalgia; Nausea, Oedema peripheral, Pain, Pruritus, Pyrexia; Urticaria More
103.9 temp x 3 days, fever, chills, nausea, severe muscle aches, shooting pain in right arm to finge... 103.9 temp x 3 days, fever, chills, nausea, severe muscle aches, shooting pain in right arm to finger tips on day 2, weakness, fatigue, severe arm pain at injection site for 2 days. On day 6, deep red welts and edema appeared on arm, spreading, itching. More
2847009 55 M FL 06/23/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 kr75k
Inappropriate schedule of product administration Inappropriate schedule of product administration
Patient previously received the Boostrix on 8/17/24, so this is a duplicated vaccine. The vaccine o... Patient previously received the Boostrix on 8/17/24, so this is a duplicated vaccine. The vaccine on 8/17/24 was not reported to FL shots, so the pharmacist was unaware that it was previously given last year. More
2847016 0.33 M CA 06/23/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 EB499
Dizziness, Presyncope Dizziness, Presyncope
Patient felt dizzy and nearly fainted after receiving the vaccine. Pt's father and Health Profe... Patient felt dizzy and nearly fainted after receiving the vaccine. Pt's father and Health Professional moved pt from immunization area to another chair. When pt was asked how he felt, pt responded feeling lightheaded, dizzy, about to faint. Pharmacy offered to call 911, but pt's father declined. After sitting on chair for approximately 10 minutes and drinking water, pt reported dizziness was gone, responded no other side effects, he able to walk normally. Pt's father stated afterwards he was likely too nervous getting vaccine. More
2846802 25 M CO 06/22/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 30145BA
30145BA
EW0196
EW0196
COVID-19, Dizziness, Fatigue, Heart rate increased, Laboratory test; Palpitation... COVID-19, Dizziness, Fatigue, Heart rate increased, Laboratory test; Palpitations, Syncope; COVID-19, Dizziness, Fatigue, Heart rate increased, Laboratory test; Palpitations, Syncope More
Dizziness/faint, racing heart, fatigue, got covid 2 days after the event. Dizziness/faint, racing heart, fatigue, got covid 2 days after the event.
✓ ✓
2846803 75 M TN 06/22/2025 COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
 EJ1686
EL3246
Cardiac arrest, Death; Cardiac arrest, Death Cardiac arrest, Death; Cardiac arrest, Death
Death due to Cardiac arrest Death due to Cardiac arrest
✓
2846804 58 F TN 06/22/2025 MMR
 MERCK & CO. INC.
Condition aggravated, Vertigo Condition aggravated, Vertigo
Symptoms of vertigo after getting the booster shot. Not sure it was related to the vaccine since I?v... Symptoms of vertigo after getting the booster shot. Not sure it was related to the vaccine since I?ve had vertigo before and it can recur I think.! More
2846805 06/22/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Incomplete course of vaccination Incomplete course of vaccination
missed the 6 month window for second dose; This non-serious case was reported by a consumer via inte... missed the 6 month window for second dose; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included shingles vaccine (received 1st dose of vaccine on an unknown date). On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: missed the 6 month window for second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 13-JUN-2025 This case was reported by a patient via interactive digital media. It had been 8 months since he/she had received his/her first shingles vaccine; he/she had missed the 6-month window for the second dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. More
2846806 1 F AR 06/22/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 GG39D
Expired product administered Expired product administered
Infanrix expired (less than 30 days) dose administration; This non-serious case was reported by a nu... Infanrix expired (less than 30 days) dose administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 20-month-old female patient who received DTPa (Infanrix) (batch number GG39D, expiry date 05-JUN-2025) for prophylaxis. On 12-JUN-2025, the patient received the 4th dose of Infanrix. On 12-JUN-2025, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Infanrix expired (less than 30 days) dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-JUN-2025 A Licensed Practical Nurse wanted to know how to proceed after administering an expired dose of Infanrix on 12th June 2025 to a patient, which led to Expired vaccine used. It was intended to be the fourth dose in the immunization schedule. More
2846807 33 SC 06/22/2025 UNK
 UNKNOWN MANUFACTURER
Off label use Off label use
Intentional Off Label Prescription by HCP: Imovax prescribed with off labe ldiagnosis Bitten by dog,... Intentional Off Label Prescription by HCP: Imovax prescribed with off labe ldiagnosis Bitten by dog, initial encounter, with no reported adverse event; Initial information received on 18-Jun-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 33-year-old and unknown gender patient who was intentionally prescribed with IPV (VERO) [Imovax] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a intentional prescription of 1ml dose of suspect IPV (VERO) Suspension for injection, frequency-4 times (lot number, strength and expiry date-unknown) via unknown route in unknown administration site for bitten by dog, initial encounter (Animal bite) with no reported adverse event (off label use). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. More
2846808 41 F GA 06/22/2025 TDAP
 SANOFI PASTEUR
 4CA04C1
Contusion, Pain in extremity, Peripheral swelling, Pruritus, Urticaria Contusion, Pain in extremity, Peripheral swelling, Pruritus, Urticaria
My arm began to experience pain, swelling from shoulder to wrist, hives, itching, & bruising. Th... My arm began to experience pain, swelling from shoulder to wrist, hives, itching, & bruising. The pain started short after the injection, however, I didn?t realize my arm was in hives until around 4 or 5 hours because the itching wouldn?t stop. I took an antihistamine of Claritin, hydrocortisone ointment, I applied aloe, cold cloth thru out the day. Today is 6/22/25 and my arm still has a bruise, slight pain on the bruise, & minor swelling. It?s much better, but not 100%. More
2846809 13 F SD 06/22/2025 HPV9
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.


Agitation, Amnesia, Computerised tomogram head normal, Delusion, Dizziness; Dysa... Agitation, Amnesia, Computerised tomogram head normal, Delusion, Dizziness; Dysarthria, Headache, Hypersomnia, Hypoaesthesia, Irritability; Mental impairment, Nausea, Somnolence, Vision blurred, Vomiting More
My daughter had numbness go down her riight ring finger, then middle, then index and thumb. She fel... My daughter had numbness go down her riight ring finger, then middle, then index and thumb. She felt like she had an explosion on the right side of her head. The headache intensified until she felt nauseous. Then she had trouble visually focusing , she repeatedly stated she couldn't think, asked what happened, had short-term memory loss. I took her to the ER. She had a CT scan done to her head which revealed no skull fractures or issues with any veins. As she was in the ER she became increasingly agitated and irritable. She started slurring her speech. She had trouble staying awake. She was given Tylenol and Zofran and sent home with me. She vomited 5 times after she got home. She called her face a foot, her glasses contacts, her shoes she called glasses. Eventually she fell asleep. (the doctor said it was ok to let her sleep). She slept for 17 hours. Woke up with headache and dizziness. She has had a headache ever since and today is 6/22/25. More
✓
2846810 39 M GA 06/22/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 301358A
301358A
301358A
FF2588
FF2588
FF2588
Blood creatinine, Cardiac disorder, Cardiac stress test, Cardiomyopathy, Compute... Blood creatinine, Cardiac disorder, Cardiac stress test, Cardiomyopathy, Computerised tomogram heart; Echocardiogram, Ejection fraction decreased, Electrocardiogram, Fatigue, Haematocrit; Magnetic resonance imaging heart, Pain in extremity, Scan with contrast; Blood creatinine, Cardiac disorder, Cardiac stress test, Cardiomyopathy, Computerised tomogram heart; Echocardiogram, Ejection fraction decreased, Electrocardiogram, Fatigue, Haematocrit; Magnetic resonance imaging heart, Pain in extremity, Scan with contrast More
Initially, sore arm, fatigue, no major illness detected. Within 3 months, I developed a heart condit... Initially, sore arm, fatigue, no major illness detected. Within 3 months, I developed a heart condition. I assumed it would go away or get better. Combine that with my career (Pilot), I can't have medical tests that will show adversely against my medical. I didn't test anything until March 2024 when I was diagnosed with cardiomyopathy, low ejection fraction. More
✓ ✓
2846811 64 F GA 06/22/2025 HEP
PNC21
 DYNAVAX TECHNOLOGIES CORPORATION
MERCK & CO. INC.
 946062
Z002626
Injection site erythema, Injection site pruritus; Injection site erythema, Injec... Injection site erythema, Injection site pruritus; Injection site erythema, Injection site pruritus More
Redness and itching at injection site Redness and itching at injection site
2846812 68 F FL 06/22/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
Extra dose administered Extra dose administered
duplicate duplicate
2846825 71 F CA 06/22/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
 041L20A
041L20A
041L20A
044A21A
044A21A
044A21A
Chromosomal analysis, Computerised tomogram head, Flow cytometry, Full blood cou... Chromosomal analysis, Computerised tomogram head, Flow cytometry, Full blood count, Headache; Immediate post-injection reaction, Laboratory test, Mantle cell lymphoma, Mobility decreased, Next-generation sequencing; Positron emission tomogram, Tinnitus; Chromosomal analysis, Computerised tomogram head, Flow cytometry, Full blood count, Headache; Immediate post-injection reaction, Laboratory test, Mantle cell lymphoma, Mobility decreased, Next-generation sequencing; Positron emission tomogram, Tinnitus More
Bedridden x2 days, headache, tinnitus, Mantel Cell Lymphoma. Headache began immediately after, tinn... Bedridden x2 days, headache, tinnitus, Mantel Cell Lymphoma. Headache began immediately after, tinnitus soon after, Mantel Cell Lymphoma diagnosis 1/2025 More
✓ ✓
2846832 36 F MD 06/22/2025 IPV
YF
 SANOFI PASTEUR
SANOFI PASTEUR

Injection site erythema, Injection site pain, Injection site pruritus, Injection... Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling; Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling More
Rash/swelling/tenderness/itching @ site of yellow fever injection 4.5 x 5.5 cm area of erythema. Rash/swelling/tenderness/itching @ site of yellow fever injection 4.5 x 5.5 cm area of erythema.
2846778 OH 06/21/2025 HPV9
 MERCK & CO. INC.
 X019196
Expired product administered, No adverse event Expired product administered, No adverse event
Nurse confirmed the patient involved has not reported any medical concerns or symptoms after being a... Nurse confirmed the patient involved has not reported any medical concerns or symptoms after being administered the expired dose of GARDASIL 9. No additional AE; expired administration of a dose of GARDASIL 9; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 16-JUN-2025, the patient was inadvertently vaccinated with an expired vaccine of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) prefilled syringe, 0.5 mL, Two or Three dose series, administered as prophylaxis (lot number X019196 has been verified to be valid for Human Papillomavirus 9-valent Vaccine, Recombinant [GARDASIL 9], expiration date 25-APR-2025; dose, formulation, anatomical site of injection, and route of administration were not reported) (Expired product administered). Nurse confirmed the patient involved has not reported any medical concerns or symptoms after being administered the expired dose of the vaccine (No adverse event). No additional information provided. More
2846783 84 F FL 06/21/2025 COVID19
 NOVAVAX
Fatigue, Muscle spasms, Pyrexia Fatigue, Muscle spasms, Pyrexia
Extreme fatigue, fever severe leg cramps for one hour in evening Extreme fatigue, fever severe leg cramps for one hour in evening
2846784 53 F CA 06/21/2025 PNC21
PNC21
PNC21
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.


Arthralgia, Dizziness, Gait disturbance, Injection site pain, Lethargy; Musculos... Arthralgia, Dizziness, Gait disturbance, Injection site pain, Lethargy; Musculoskeletal chest pain, Myalgia, Nausea, Pain, Pyrexia; Rash, Sensitive skin More
0 hours: injection site pain, soreness; <12 hours muscle ache, joint pain, overall body ache, fee... 0 hours: injection site pain, soreness; <12 hours muscle ache, joint pain, overall body ache, feeling of sensitive skin (i.e. skin hurts to touch); <24 hours feverish, increased overall body aches and pains, lethargy, pain lower right rib. Began 1g (2*500mg) acetaminophen Q6 hours for symptoms; <48 hours dizziness, nausea, unsteady gait, overall body pain and muscle aches (discontinue acetaminophen); >48 hours painful rash posterior to injection site on right arm, pruritis (very itchy), >72 hours pain lower right rib persists (constant, not off and on) especially if taking deep breath, pruritis on and below injection site including red rash area, placed topical salonpas patch on area to prevent scratching. More
2846785 63 F NM 06/21/2025 PNC21
 MERCK & CO. INC.
 Y019157
Erythema, Induration, Muscle swelling, Skin warm Erythema, Induration, Muscle swelling, Skin warm
Pt complained of swollen deltoid, hot to touch, hard swelling. Red "finger" marks. Pt complained of swollen deltoid, hot to touch, hard swelling. Red "finger" marks.
2846786 60 F CA 06/21/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH

Cellulitis, Chills, Erythema, Feeling hot, Pain in extremity; Peripheral swellin... Cellulitis, Chills, Erythema, Feeling hot, Pain in extremity; Peripheral swelling More
Chills redness of arm swelling of arm - arm pain- arm felt warm - redness spread everyday further do... Chills redness of arm swelling of arm - arm pain- arm felt warm - redness spread everyday further down to elbow and spread side ways surrounding the arm - continue to spread for about 5-6 days. On 6 days seek medical attention and was given Cephalexin 500mg q6h - was told for cellulitis - symptoms - subsided - finishing the 7 day course of antibiotics right now - More
2846787 59 F AZ 06/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 75D3A
Dizziness, Lip swelling, Nausea, Syncope Dizziness, Lip swelling, Nausea, Syncope
The patient received her 2nd dose of Shingrix vaccine on 6/19/2025. Patient reported that 36 hours a... The patient received her 2nd dose of Shingrix vaccine on 6/19/2025. Patient reported that 36 hours after she received the vaccination, in the early am on 6/21/2025, she woke up with a swelling upper lip, nausea, and syncope. She called the pharmacy at 10:15 am 6/21/2025 and reported her reactions with still a swollen upper lip and feeling like she was going to "black out" when she stands up. I recommended going to the emergency room, she was accompanied by her daughter at the time of the call. More
2846788 51 F GA 06/21/2025 PNC21
 MERCK & CO. INC.
 z002626
Injection site erythema, Injection site reaction, Injection site warmth Injection site erythema, Injection site reaction, Injection site warmth
injection site reaction with redness swelling and heat. advised to use topical benedryl injection site reaction with redness swelling and heat. advised to use topical benedryl
2846789 57 F GA 06/21/2025 PNC21
VARZOS
 MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
 z002626
3j2s2
Injection site erythema, Injection site swelling, Injection site warmth; Injecti... Injection site erythema, Injection site swelling, Injection site warmth; Injection site erythema, Injection site swelling, Injection site warmth More
injection site reaction redness, swelling, heat on arm - recommended benedryl cream injection site reaction redness, swelling, heat on arm - recommended benedryl cream
2846790 79 F NY 06/21/2025 RSV
 PFIZER\WYETH
Cough, Dyspnoea, Rhinorrhoea Cough, Dyspnoea, Rhinorrhoea
cough and runny nose from the outset.....nothing helped. On March 24, 2025. I awoke UNABLE TO BREAT... cough and runny nose from the outset.....nothing helped. On March 24, 2025. I awoke UNABLE TO BREATHE. Managed to call EMS and was rushed to the hospital, in which was a patient for an entire week. When I was discharged, I came home with inhalers, nose drops AND OXYGEN!!!! Never been on oxygen in my life!!! Now I'm stuck with it!!! More
✓ ✓
📋 Privacy Policy & Data Disclaimer